Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Roche Holding Ltd
(OP:
RHHBF
)
362.50
+4.50 (+1.26%)
Streaming Delayed Price
Updated: 3:18 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Roche Holding Ltd
< Previous
1
2
3
4
5
6
7
Next >
New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients
March 20, 2023
Via
Benzinga
FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting
March 09, 2023
Via
Benzinga
Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo
March 03, 2023
Via
Benzinga
Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines
February 23, 2023
Via
Benzinga
New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder
February 10, 2023
Via
Benzinga
Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition
February 07, 2023
Via
Benzinga
Roche Introduces Test To Detect Contagious XBB.1.5 Omicron Sub-Variant
January 26, 2023
Via
Benzinga
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
February 02, 2023
Via
Benzinga
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
January 19, 2023
Via
Benzinga
Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
January 12, 2023
Via
Benzinga
Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review
January 06, 2023
Via
Benzinga
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Via
Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
Via
Benzinga
Roche Presents New Data Demonstrating Potential Benefit Of Two Lymphoma Candidates
December 12, 2022
Via
Benzinga
After 16 Years, Roche's Pharma Division Head Decides To Step Down
December 12, 2022
Via
Benzinga
Replimune Shares Surge After Early Data From Pretreated Melanoma Patients
December 07, 2022
Via
Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
Via
Benzinga
FDA Gives Emergency Use Nod To Roche's Monkeypox Test
November 16, 2022
Via
Benzinga
Successful Alzheimer's Data Would Have Placed Roche At Two-Year Competitive Advantage
November 15, 2022
Via
Benzinga
Roche Inks Second Drug Discovery Deal With Jnana Therapeutics
November 15, 2022
Via
Benzinga
Roche's Alzheimer's Flop Trial Removes One Competitor, But Reimbursement Debate Lingers
November 14, 2022
Via
Benzinga
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
November 14, 2022
Via
Benzinga
Why Is Hookipa (HOOK) Stock Up 26% Today?
October 20, 2022
Hookipa (HOOK) stock is rocketing higher on Thursday after reaching a strategic collaboration and license agreement with Roche (RHHBF).
Via
InvestorPlace
Roche Posts Lower Quarterly Sales As Demand For COVID Products Slide
October 18, 2022
Via
Benzinga
Roche's Muscular Atrophy Treatment Improves Motor Function In Pretreated Patients
October 12, 2022
Via
Benzinga
Roche To Introduce Next-Generation Portfolio Of COVID-19 Rapid Tests
October 12, 2022
Via
Benzinga
EXCLUSIVE: Lineage Cell Establishes New R&D Facility In US, Expands Israel-Based Facility
October 03, 2022
Lineage Cell Therapeutics Inc (NYSE: LCTX) has opened a new research and development facility in Carlsbad, California.
Via
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Via
Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
September 23, 2022
The World Health Organization (WHO) warned that it struggles to identify and
Via
Benzinga
Europe Approves First Bispecific Antibody From Roche For Two Eye Disorders
September 19, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.